INTRODUCTION
============

The host innate immune system is a first line defense mechanism against bacterial, viral and fungal infection ([@b1-molcell-38-1-26]). The activation of the innate immune response rapidly regulates the replication of microorganisms and induces the development of adaptive immunity. Antigen-presenting cells (APCs), such as macrophages, dendritic cells (DCs) and B cells, express various pattern recognition receptors (PRRs) and recognize pathogen derived pathogen-associated molecular patterns (PAMPs), including lipids, proteins, lipoproteins and nucleic acids ([@b15-molcell-38-1-26]; [@b21-molcell-38-1-26]). TLR is one of the best studied PRR families, and these proteins recognize various microorganism-derived nucleotides, such as dsRNA (TLR3), ssRNA (TLR7) and bacterial CpG DNA (TLR9). After recognition of specific ligands, most TLRs, except TLR3, induce the recruitment of adaptor proteins, such as MyD88, IRAK and TRAF6, and increase the expression of inflammatory cytokines, type I interferon (IFN), chemokines and costimulatory molecules through the activation of NF-κB and MAPK pathways ([@b2-molcell-38-1-26]).

Although the inflammatory response regulates the growth of microorganisms to protect host cells, immoderate cytokine production damages the host cells ([@b5-molcell-38-1-26]; [@b6-molcell-38-1-26]; [@b17-molcell-38-1-26]). Recent studies have suggested that repeated exposure to endotoxin (such as lipopolysaccharide; LPS) induces an "endotoxin tolerance", which does not respond to endotoxin ([@b8-molcell-38-1-26]; [@b14-molcell-38-1-26]). Endotoxin tolerance is a negative feedback mechanism to protect the host against endotoxin shock and the negative regulation of TLR signaling through proteins, such as IRAK-M, SOCS-1 and A20 ([@b10-molcell-38-1-26]; [@b18-molcell-38-1-26]; [@b23-molcell-38-1-26]). Therefore, innate immunity is tightly controlled through the signaling of negative regulators that inhibit excessive cytokine production. However, the tolerance induced through the repetitive stimulation of other TLR ligands or simultaneous stimulation of different TLR ligands remains largely unknown.

In the present study, we examined whether costimulation with agonists for TLR7 and TLR9 or subsequent stimulation with the same agonists induced tolerance in mouse macrophages. The costimulation or restimulation of mouse macrophages with gardiquimod (GDQ, TLR7 agonist) and CpG oligodeoxynucleotide 1826 (ODN1826, TLR9 agonist) reduced the levels of proinflammatory cytokines TNF-α and IL-6, but the levels of anti-inflammatory cytokine IL-10 remained unchanged. Costimulation with agonists for TLR7 and TLR9 also delayed the activation of NF-κB signaling and increased the levels of SOCS-1. In addition, the expression of each TLR was significantly decreased after restimulation, while the TLR expression was rapidly recovered when the cells were stimulated with a single agonist alone. Therefore, the costimulation of TLR7 and TLR9 induced macrophage tolerance via the delayed transduction of NF-κB signaling and SOCS-1 activity, whereas restimulation down-regulated the expression of TLR in mouse macrophages.

MATERIALS AND METHODS
=====================

Reagents
--------

Gardiquimod (GDQ) (TLR7 agonist) and lipopolysaccharide (LPS) (TLR4 agonist) were purchased from InvivoGen (USA). The TLR9 agonist CpG oligodeoxynucleotide 1826 (ODN1826), which is phosphorothioated backbone-modified oligodeoxynucleotide, was purchased from GenoTech (Korea). All antibodies were purchased from Santa Cruz Biotechnology (USA) except anti-phospho-IκB, anti-phospho-MEK, anti-MEK, anti-phospho-Erk1/2 and anti-Erk1/2 (Cell Signaling Technologies, USA).

Cell culture and BMDM isolation
-------------------------------

The mouse macrophage cell line, RAW264.7 was purchased from the American Type Culture Collection (ATCC) and maintained in RPMI1640 (Lonza, USA) culture medium containing 10% heat-inactivated fetal bovine serum (FBS; Lonza, USA) and penicillin (10,000 U/L) (Gibco-BRL, USA) at 37°C, 5% CO~2~. Mouse bone marrow-derived macrophages (BMDMs) were isolated from 8-week-old wild-type C57BL/6 and BALB/c male mice (Nara Bio., Korea). Briefly, BMDMs were obtained after culturing bone marrow-derived mononuclear precursor cells isolated from the femurs and tibiae in RPMI1640 medium supplemented with 10% heat-inactivated fetal bovine serum, penicillin (10,000 U/L) and 20% L-929 cell conditioned medium at 37°C and 5% CO~2~ for 3 days.

Cell transfection
-----------------

The siRNA target sequence for mouse SOCS-1 was purchased from Santa Cruz Biotechnology (USA). The cells were transfected with 60 pmol siSOCS-1 using the Lipofectamine reagent (Invitrogen, USA) in serum-free medium according to the manufacturer's instructions. The cells were incubated at 37°C and 5% CO~2~ for 6 h and recovered for an additional 6 h before treatment with TLR agonists.

Enzyme-linked immunosorbent assay (ELISA)
-----------------------------------------

The concentration of mouse TNF-α, IL-6 and IL-10 in the cell culture media was determined using an enzyme-linked immunosorbent assay (ELISA). RAW264.7 cells and BMDMs (1 × 10^5^ cells/well) were seeded onto a 24--well plate and stimulated with either agonists of TLR7 and TLR9 or both at 37°C and 5% CO~2~. After overnight incubation, the cells were washed with PBS (phosphate-buffered saline; Gibco BRL Life Technologies, USA) and incubated overnight in RPMI1640 medium. Subsequently, the cells were restimulated with TLR agonists for 1 h under the same conditions. Cell-free supernatants were obtained from siRNA-transfected cells. The murine TNF-α, IL-6 and IL-10 ELISA development kit was purchased from Peprotech (USA) and the mouse IL-1β and IL-1Ra Duoset® ELISA development system was purchased from R&D System, Inc. (USA). The cytokine levels in cell-free supernatants were determined using ELISA according to the manufacturer's instruction.

Western blot analysis
---------------------

The extracted proteins were resolved on 10 to 15% SDS-polyacrylamide gels through electrophoresis, followed by transfer onto a PVDF transfer membrane (Millipore, USA). The blots were incubated with 5% skim milk in 0.1% TBS-T for 1 h, and subsequently washed in 0.1% TBS-T (20 mM Tris, 150 mM NaCl, pH 8.0 and 1% Tween 20)([@b12-molcell-38-1-26]). The membranes were incubated with the primary antibodies followed by washing and labeling with an HRP-conjugated secondary antibody in 0.1% TBS-T. The blot was treated with ECL (Animal Genetics Inc., Korea) and exposed to Kodak XAR film (USA) in the darkroom.

Nuclear and cytoplasmic extraction and immunoprecipitation
----------------------------------------------------------

Cells were lysed with buffer A (10 mM HEPES, 10 mM KCl, 0.1 mM EGTA, 0.1 mM EDTA, 1 mM DTT, 0.3% NP-40) containing protease inhibitor for 15 min and centrifuged for 5 min at 4,000 r.p.m. Supernatant corresponding to cytoplasm was saved and kept on ice. The pellet was resuspended with buffer B (25 mM HEPES, 0.5 mM EDTA, 0.4 M NaCl, 1 mM DTT) containing protease inhibitor and incubated for 30 min at 4°C. Lysate was centrifugated for 10 minutes at 10,000 r.p.m and the supernatant corresponding to nuclear extract was separated for immuneprecipitation input control. For immunoprecipitation analysis, phospho-NF-κB p65 antibody or SOCS-1 antibody and protein G plus/protein A beads (Millipore, USA) was added in nuclear extract and incubated for overnight at 4°C on a rotator. Finally, lysate was washed three times with IP buffer (50 mM Tris-HCl, pH7.5, 250 mM NaCl, 0.5% NP-40), and denaturated with SDS at 95°C for 5 min.

Total RNA isolation and RT-PCR
------------------------------

The RNA extraction was performed using an RNeasy mini kit (Qiagen, USA) according to the manufacturer's instruction. Briefly, 2 μg of total RNA was reverse transcribed using M-MLV RT (Enzynomics, Korea) in a reaction including RNase inhibitors and a random hexamer (Takara, Japan) according to the manufacturer's instructions. The PCR reaction was performed with forward and reverse primers and 0.5 μl of Taq polymerase (Takara, Japan). The nucleotide sequences of the RT-PCR primers and the sizes of amplified products are described in [Supplementary Table S1](#SD1){ref-type="supplementary-material"}. The amplified products were separated on 1.5% agarose gel and visualized after staining with ethidium bromide (Sigma-Aldrich, USA). The expression of the housekeeping genes, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and β-actin was determined as an internal control.

Luciferase assay
----------------

RAW264.7 cells were transiently transfected with a NF-κB reporter construct (Promega, USA) using lipofectamine 2000. The cells were stimulated with either agonists for TLR7 and TLR9 or both. Subsequently, the cells were washed with PBS and incubated overnight in RPMI1640 medium at 37°C and 5% CO~2~. And then, the cells were restimulated with TLR agonists for 1 h under the same conditions and lysed in 100 μl of luciferase cell culture lysis reagent (Promega, USA). The NF-κB promoter activity was measured using the Dual-Luciferase Reporter Assay System (Promega, USA) and the results were obtained using luminometer according to the manufacturer's specifications.

Flow cytometry
--------------

RAW264.7 cells were stimulated with agonists for TLR7 and TLR9 or both for 4 or 16 h, followed by fixation and permeabilization with 4% paraformaldehyde and 0.1% saponin. After washing, the cells were incubated with anti-mouse Alexa Fluor® 488-conjugated TLR7 monoclonal antibody (mAb) or anti-mouse Alexa Fluor® 488-conjugated TLR9 mAb (IMGENEX, USA) for 30 min at 4°C in the dark. Subsequently, the cells were washed twice with cold PBS, supplemented with 2% FBS. The absorbance was read on a BD-FACSCalibur instrument (BD-Biosciences, USA) and flow cytometric analysis was performed with Cell Quest (BD-Biosciences) software.

Statistical analysis
--------------------

The data were obtained from independent experiments. The levels of significance for comparison between samples were determined with unpaired Student's *t*-tests using GraphPad Prism 5 software (GraphPad Software, USA). Statistical significance was indicated as \*P \< 0.05, \*\*P \< 0.01, \*\*\*P \< 0.001 and n.s., not significant (P \< 0.05).

RESULTS
=======

TLR stimulation induces the innate immune response through the increased secretion of proinflammatory cytokines, such as TNF-α, IL-1β and IL-6 ([@b1-molcell-38-1-26]). To determine whether the excessive stimulation of both TLR7 and TLR9 induces hyperresponsiveness or hyporesponsiveness in mouse macrophages, proinflmmatory and anti-inflammatory cytokines were measured using an ELSIA assay. The production of TNF-α was decreased when RAW264.7 cells were simultaneously stimulated with agonists for TLR7 and TLR9 compared with cells stimulated agonists for either TLR7 or TLR9 alone ([Fig. 1A](#f1-molcell-38-1-26){ref-type="fig"}). Decreased TNF-α expression was observed in both BALB/c and C57BL/6 BMDMs ([Fig. 1A](#f1-molcell-38-1-26){ref-type="fig"}). Moreover, the restimulation of TLRs decreased TNF-α secretion, when macrophages were stimulated with agonists for either TLR7 or TLR9 or both overnight, followed by treatment with the same agonists for 1 h ([Fig. 1B](#f1-molcell-38-1-26){ref-type="fig"}). IL-6 levels were significantly reduced in both costimulated and restimulated groups ([Fig. 1C](#f1-molcell-38-1-26){ref-type="fig"}). However, the secretion of IL-10 and IL-1β remained unchanged ([Fig. 1D](#f1-molcell-38-1-26){ref-type="fig"} and [Supplementary Fig. S1](#SD1){ref-type="supplementary-material"}). These results showed that costimulation and restimulation with specific agonists for TLR7 and TLR9 induced tolerance through a reduction in the levels of proinflammatory cytokines in mouse macrophages.

The association of TLRs with specific ligands stimulates the recruitment of TLR signaling mediators, such as IRAK4, IRKA1, TRAF6 and the IKK family, through the MyD88 pathway, resulting in the subsequent activation of NF-κB ([@b13-molcell-38-1-26]). The MyD88 pathway also activates the MAPK pathway. To further examine the reduction of proinflammatory cytokine expression in macrophages costimulated with both agonists for TLR7 and TLR9, the molecules involved in the NF-κB pathway and the MAPK pathway were determined using western blot analysis. IRAK-1, which transmits a signal to the IKK complex via degradation through auto-phosphorylation, was degraded at 1 h after stimulation with a single agonist, but the expression of this molecule was sustained at 3 h after costimulation of both TLRs ([Fig. 2A](#f2-molcell-38-1-26){ref-type="fig"}). The rapid degradation of IκBα results in the translocation of NF-κB to the nucleus; less Iκ Bα degradation was detected when cells were stimulated with both agonists for TLR7 and TLR9 compared with cells stimulated with a single agonist ([Fig. 2A](#f2-molcell-38-1-26){ref-type="fig"}). In addition, the delayed translocation of NF-κB p65 to nuclear was observed when RAW264.7 cells were simultaneously stimulated with agonists for TLR7 and TLR9 ([Fig. 2B](#f2-molcell-38-1-26){ref-type="fig"}). However, the expression of phosphorylated MEK, ERK and p38 remained unchanged between single and costimulated samples.

To further confirm the reduction in NF-κB signaling through costimulation or restimulation with agonists for TLR7 and TLR9, the promoter activity of NF-κB was assessed using luciferase assays. As shown in [Fig. 2C](#f2-molcell-38-1-26){ref-type="fig"}, NF-κB promoter activity was significantly decreased when macrophages were simultaneously stimulated or restimulated with both agonists compared with cells stimulated with a single agonist ([Fig. 2C](#f2-molcell-38-1-26){ref-type="fig"}).

Negative regulators of TLR signaling, such as A20, IRAK-M, SOCS-1 and SOCS-3, reduce or terminate the innate immune response ([@b11-molcell-38-1-26]; [@b16-molcell-38-1-26]). Thus, involvement of negative regulators of TLR signaling in the induction of tolerance in mouse macrophages costimulated with both TLR7 and TLR9 was assessed. The expression of SOCS-1 was significantly increased at 30 min to 1 h after the costimulation of RAW264.7 cells; notably, there was no change in the expression levels of IRAK-M or SOCS-3 ([Figs. 3A](#f3-molcell-38-1-26){ref-type="fig"} and [3B](#f3-molcell-38-1-26){ref-type="fig"}). After stimulation with agonists for either TLR7 or TLR9 or both overnight, the level of TNF-α secretion was significantly increased in the cells with transiently abolished SOCS-1 mRNA expression compared with cells transfected with scrambled RNA ([Fig. 3C](#f3-molcell-38-1-26){ref-type="fig"}). The inhibition of SOCS-1 did not significantly affect the levels of TNF-α in siSOCS-1-transfected RAW264.7 cells restimulated with agonists for either TLR7 and TLR9 or both ([Fig. 3C](#f3-molcell-38-1-26){ref-type="fig"}).

To identify whether the delayed NF-κB activity is due to the degradation of ubiquitinated p65 subunit, expression of molecules involved in NF-κB signaling pathway were measured after knockdown of SOCS1 using siRNA in RAW264.7 cells. The rapid degradation and phosphorylation of IκBα was observed in siSOCS-1-knockdown macrophages stimulated with agonists for either TLR7 or TLR9 or both ([Fig. 4A](#f4-molcell-38-1-26){ref-type="fig"}). Furthermore, to investigate whether endogenous SOCS-1 and NF-κB p65 interact in nucleus, phosphor-NF-κB p65 or SOCS-1 was immuno- precipitated from nuclear extracts of macrophage stimulated with single or both agonists. Endogenous p65 and SOCS-1 were coimmunoprecipitated and costimulation induced a stronger p65 ubiquitination in mouse macrophages compared with single stimulation ([Fig. 4B](#f4-molcell-38-1-26){ref-type="fig"}).

A previous study has shown that the expression of TLRs was reduced through the stimulation of TLRs with specific agonists ([@b22-molcell-38-1-26]). To verify whether the observed macrophage tolerance reflected the inadequate expression of TLRs in cells restimulated with either or both agonists, the expression of TLR7 and TLR9 was measured at the transcriptional and translational levels. The results showed that the expression of TLR7 or TLR9 mRNA was less detectable when RAW264.7 cells were restimulated with each agonist alone ([Fig. 5A](#f5-molcell-38-1-26){ref-type="fig"}). The expression of both TLR7 and TLR9 was significantly decreased when the cells were simultaneously restimulated with both agonists. The decreased expression of TLR7 and TLR9 proteins was detected when both TLRs were stained with fluorescence dye-conjugated antibodies and measured using flow cytometry. The expression of TLR7 and TLR9 was restored at 4 h after stimulation with each agonist; in contrast, both TLRs expression was not restored until 16 h after costimulation with both agonists ([Figs. 5B](#f5-molcell-38-1-26){ref-type="fig"} and [5C](#f5-molcell-38-1-26){ref-type="fig"}). These results suggested that single TLR stimulation diminished TLR expression for several hours, while costimulation reduced the expression of both TLRs for at least 16 h.

DISCUSSION
==========

The results obtained in the present study demonstrated that the simultaneous stimulation and restimulation of TLR7 and TLR9 with specific agonists induced tolerance in mouse macrophages, thereby reducing the production of proinflammatory cytokines TNF-α and IL-6. The simultaneous stimulation-mediated tolerance impaired NF-κB activation through the delayed degradation of IRAK-1 and IκB, which reduced the secretion of these cytokines.

Recent studies have shown that the expression of negative regulators, such as SOCS-1 ([@b18-molcell-38-1-26]), IRAK-M ([@b9-molcell-38-1-26]; [@b19-molcell-38-1-26]; [@b23-molcell-38-1-26]; [@b25-molcell-38-1-26]), SH2-containing inositol-5′-phosphatase-1 (SHIP-1) ([@b23-molcell-38-1-26]; [@b24-molcell-38-1-26]) and A20 ([@b24-molcell-38-1-26]), is enhanced under tolerant conditions; specifically, the involvement of IRAK-M has previously been reported in endotoxin tolerance ([@b19-molcell-38-1-26]). As proposed in [Fig. 3](#f3-molcell-38-1-26){ref-type="fig"}, the increased expression of SOCS-1, but not other regulators, was detected in simultaneous-stimulated mouse macrophages. In addition, the knockdown of SOCS-1 induced the increased production of TNF-α in the cells stimulated overnight with both agonists for TLR7 and TLR9, although SOCS-1 was not involved in the tolerance induced through the restimulated TLRs, as shown in [Fig. 3C](#f3-molcell-38-1-26){ref-type="fig"}. The inhibition of SOCS-1 was able to strongly rescue NF-κB activity in costimulated mouse macrophages, according to the accelerated degradation and phosphorylation of IκBα. Furthermore, following costimulation, SOCS-1 and NF-κB p65 subunit trans-located to the nucleus, where they were interacted and induced the ubiquitination of NF-κB p65 subunit ([Fig. 4](#f4-molcell-38-1-26){ref-type="fig"}). These results suggest that the delayed activation of NF-κB signaling is due to differential posttranslational modification of NF-κB p65 in costimulated cells. Therefore, the involvement of SOCS-1 in tolerance through simultaneous stimulation decreases TNF-α levels through the inhibition of NF-κB activation to induce the degradation of IRAK-1 and IκB ([@b20-molcell-38-1-26]).

Taken together, these results suggest that the excessive stimulation of TLRs reduces the expression of TLRs for several hours. This finding could explain why cells costimulated with both agonists of TLR7 and TLR9 did not secrete proinflammatory cytokines during the restimulation. These endosomal TLRs play important roles in recognition and antigen processing after viral infection. Specifically, when host cells are infected with RNA viruses, such as, hepatitis C virus (HCV), influenza virus and human immunodeficiency virus (HIV), host APCs could encounter viral RNA or DNA or both during viral replication. Thus, as TLR7 and TLR9 could be simultaneously or repeatedly activated, the tolerance induced through these endosomal TLRs could serve the defective innate immune mechanisms in chronic viral infections.

It has recently been reported that TLR7 expression is downregulated in the livers of HCV-infected patients ([@b7-molcell-38-1-26]) and responses to TLR9 stimulation were universally decreased in all HIV-1-infected individuals ([@b3-molcell-38-1-26]). It has also been suggested that innate immunity is impaired after secondary bacterial infections following influenza, resulting in susceptibility to bacterial pneumonia ([@b4-molcell-38-1-26]).

Therefore, these findings suggest that chronic viral infection leads to immune hyporesponssiveness, and acute influenza infection induces susceptibility to secondary bacterial infections.
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![Costimulation and/or restimulation of TLR7 and TLR9 decreased the levels of proinflammatory cytokine production in mouse macrophages. (A) Mouse macrophages were stimulated with either an agonist for TLR7 (GDQ) or TLR9 (ODN 1826) or both (GDQ + ODN1826) overnight (1st), and the production of TNF-α in the supernatant was measured using ELISA. LPS stimulation was introduced as a positive control. □ Raw264.7 macrophage cell line, and ▪ BMDMs from Balb/c mice. (B) After the first stimulation, the cells were washed with PBS and incubated with culture media overnight. Subsequently, the cells were restimulated with TLR agonists for 1 h (2nd), and the production of TNF-α was measured using ELISA. The levels of IL-6 (C) and IL-10 (D) were measured in RAW264.7 cells under the same conditions. Significant differences were indicated as \*P \< 0.05, \*\*P \< 0.01, \*\*\*P \< 0.001, and n.s., not significant (P \< 0.05).](molcell-38-1-26f1){#f1-molcell-38-1-26}

![Delayed activation of NF-κB signaling in cells simultaneously stimulated with both agonists for TLR7 and TLR9. (A) RAW264.7 cells were stimulated with either an agonist for TLR7 or TLR9 or both. The cell lysates were extracted, and the changes in expression levels of TLR signaling downstream molecules were assessed using Western blot analysis. Bar graphs indicate the results of the relative densitometry compared with β-actin protein. (B) Nuclear translocation of p65 was identified within cytoplasmic (CE) and nuclear fractions (NE) by Western blotting against p65. (C) RAW264.7 cells were transfected with the NF-κB-luc reporter gene. The transfected cells were treated with either an agonist for TLR7 and TLR9 or both for 4 h (1st), followed by washing with PBS and incubation in culture media for 12 h. Subsequently, the cells were restimulated with TLR agonists for 1 h (2nd), and the NF-κB promoter activity was measured through luciferase assay. Significant differences were indicated as \*\*P \< 0.01, \*\*\*P \< 0.001, and n.s., not significant (P \< 0.05).](molcell-38-1-26f2){#f2-molcell-38-1-26}

![Upregulation of SOCS1 after TLR7 and TLR9 costimulation. (A) RAW264.7 cells were stimulated with either an agonist for TLR7 or TLR9 or both for the indicated time. The protein expression in the total lysates was analyzed by Western blotting using antibodies against A20, IRAK-M, SOCS-1 and β-actin. (B) The mRNA expression levels of A20, SOCS-3, SOCS-1, IRAK-M and β-actin were determined through RT-PCR. (C) RAW264.7 cells were transfected with siRNA targeting SOCS-1 mRNA or scrambled siRNA and stimulated with either an agonist for TLR7 or TLR9 or both overnight (1st). After stimulation, the cells were washed with PBS and incubated with culture media overnight. Subsequently, the cells were restimulated with TLR agonists for 1 h (2nd) and the production of TNF-α was measured through ELISA.](molcell-38-1-26f3){#f3-molcell-38-1-26}

![Recovered NF-κB signaling in the costimulated cells when SOCS-1 was abolished (A) RAW264.7 cells were transfected with siRNA targeting SOCS-1 mRNA or scrambled siRNA and stimulated with either an agonist for TLR7 or TLR9 or both for indicated time points. The whole cell lysates were extracted, and Western blot analysis showed the cellular levels of IRAK-1, IKK-β, IκBα and SOCS-1. α-tubulin was used as a loading control. (B) RAW264.7 cells were stimulated with each agonist for TLR7 and TLR9 or both for indicated time points, and then nuclear extracts were immunoprecipitated with anti-phospho-NF-κB p65 or anti-SOCS-1, followed by western blot analysis.](molcell-38-1-26f4){#f4-molcell-38-1-26}

![The costimulation and/or restimulation of TLR7 and TLR9 decrease the expression of TLR7 and TLR9. (A) RAW264.7 cells were stimulated with either an agonist for TLR7 or TLR9 or both overnight (1st), subsequently the cells were washed with PBS and incubated with culture media overnight. After incubation, the cells were restimulated with TLR agonists for 1 h (2nd) and the expression of TLR7 and TLR9 was measured using RT-PCR. (B) The cells were incubated with either an agonist for TLR7 and TLR9 or both for 4 or 16 h, and the expression of endosomal TLR7 and TLR9 was measured using flow cytometry. The data are presented as the mean fluorescence intensity (MFI) (C).](molcell-38-1-26f5){#f5-molcell-38-1-26}
